White Biotechnology Market Expected to Reach US$207.5 Billion by 2022-2027
White Biotechnology Market Expected to Reach US$207.5 Billion by 2022-2027
White Biotechnology Market

Market Overview:
The global White Biotechnology Market is estimated to be valued at US$207.5 billion in 2019 and is projected to reach US$281.5 billion by 2022, exhibiting a CAGR of 4.7% during the forecast period of 2020-2027. White biotechnology refers to the application of biotechnological processes in industries such as pharmaceuticals, energy, textiles, and food and beverages. It aims to replace traditional industrial practices with eco-friendly and sustainable alternatives. The increasing need for clean energy sources, rising environmental concerns, and government initiatives promoting the use of bio-based products are driving the growth of the white biotechnology market. White biotechnology offers several advantages such as reduced energy consumption, lower waste generation, improved efficiency, and cost savings. These factors are expected to propel the demand for white biotechnology products across various industries.

Market Key Trends:
One key trend in the white biotechnology market is the growing adoption of bio-based chemicals. With the increasing focus on sustainability and environmental preservation, industries are shifting towards using bio-based chemicals rather than conventional petroleum-based chemicals. Bio-based chemicals are derived from renewable sources such as plants, algae, and bacteria. They have a lower carbon footprint and are biodegradable, thus reducing the negative impact on the environment. The pharmaceutical, food and beverage, and personal care industries are among the major adopters of bio-based chemicals. Moreover, the development of advanced biotechnological processes and the availability of raw materials are driving the growth of the bio-based chemicals market. This trend is expected to continue during the forecast period, as companies strive to reduce their reliance on fossil fuels and embrace sustainable alternatives.
Segment Analysis:

The White Biotechnology Market Growth can be segmented based on application, which includes food and beverages, agriculture, bioenergy, textiles, and others. Among these segments, the food and beverages sector is expected to dominate the market during the forecast period. This is primarily due to the increasing demand for bio-based ingredients and additives in the food and beverage industry. There is a growing preference for natural and sustainable products among consumers, which has led to the adoption of white biotechnology solutions in the food and beverage sector. White biotechnology offers various benefits in terms of cost-effectiveness, environmental sustainability, and reduced reliance on fossil fuels, which further drive its demand in the food and beverages segment.

Key Takeaways:

The global White Biotechnology Market is expected to witness high growth, exhibiting a CAGR of 4.7% over the forecast period of 2020-2027. The market is primarily driven by the increasing adoption of sustainable and eco-friendly solutions across various industries. The food and beverages segment is expected to dominate the market, owing to the growing demand for bio-based ingredients and additives.

In terms of regional analysis, North America is anticipated to be the fastest-growing region in the White Biotechnology market. This is attributed to the presence of key players in the region, along with favorable government initiatives supporting the development and adoption of white biotechnology solutions. Europe is another significant market for white biotechnology, driven by strict environmental regulations and increasing investments in research and development activities.

Key players operating in the White Biotechnology Market include Archer Daniels Midland Company, BASF SE, Cargill, Inc., Corbion N.V., Koninklijke DSM N.V, DuPont, Lesaffre, Novozymes, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., iCAD, Inc., InVivo Corporation, McKesson Corporation, Merge Healthcare Incorporated (IBM), Philips Healthcare, Samsung Medison Co. Ltd., Siemens Healthcare, and Toshiba Medical Systems Corporation. These companies are focusing on strategic partnerships, mergers and acquisitions, and research and development activities to maintain their competitive edge in the market.

Read more @ https://www.pressreleasebulletin.com/white-biotechnology-market-growing-demand-for-sustainable-solutions-driving-market-growth/

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations